on Affluent Medical (isin : FR0013333077)
Affluent Medical Advances Towards SPHINX Study for Female SUI Treatment
Affluent Medical announced plans for the SPHINX pilot study, aimed at evaluating the Artus artificial urinary sphincter in women with stress urinary incontinence (SUI). The study, set to commence in the second half of 2025, will involve top medical centers in France, Spain, and Belgium. This marks a crucial development in expanding treatment options for women affected by SUI.
Professor Véronique Phé, a prominent urologist, successfully led the initial implantation of the Artus device in a female model, using minimally invasive robotic-assisted techniques. Phé highlighted the procedure’s efficiency and safety, underscoring the device's potential to enhance patient care.
Sébastien Ladet, CEO of Affluent Medical, emphasized the company's efforts to meet female urology needs and expressed confidence in the Artus device, given its success in prior male studies.
R. H.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Affluent Medical news